DE69102174D1 - Iontophoresezusammensetzung zur Erhöhung der Hautkonzentration aktiver Wirkstoffe. - Google Patents

Iontophoresezusammensetzung zur Erhöhung der Hautkonzentration aktiver Wirkstoffe.

Info

Publication number
DE69102174D1
DE69102174D1 DE69102174T DE69102174T DE69102174D1 DE 69102174 D1 DE69102174 D1 DE 69102174D1 DE 69102174 T DE69102174 T DE 69102174T DE 69102174 T DE69102174 T DE 69102174T DE 69102174 D1 DE69102174 D1 DE 69102174D1
Authority
DE
Germany
Prior art keywords
skin concentration
increasing
active ingredients
compositions
iontophoresis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69102174T
Other languages
English (en)
Other versions
DE69102174T2 (de
Inventor
Burton H Sage
James E Riviere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vyteris Inc
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/653,204 external-priority patent/US5334138A/en
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of DE69102174D1 publication Critical patent/DE69102174D1/de
Application granted granted Critical
Publication of DE69102174T2 publication Critical patent/DE69102174T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DE69102174T 1990-03-15 1991-03-15 Iontophoresezusammensetzung zur Erhöhung der Hautkonzentration aktiver Wirkstoffe. Expired - Fee Related DE69102174T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49406290A 1990-03-15 1990-03-15
US07/653,204 US5334138A (en) 1990-03-15 1991-02-08 Method and composition for increased skin concentration of active agents by iontophoresis

Publications (2)

Publication Number Publication Date
DE69102174D1 true DE69102174D1 (de) 1994-07-07
DE69102174T2 DE69102174T2 (de) 1994-09-08

Family

ID=27051283

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69102174T Expired - Fee Related DE69102174T2 (de) 1990-03-15 1991-03-15 Iontophoresezusammensetzung zur Erhöhung der Hautkonzentration aktiver Wirkstoffe.

Country Status (11)

Country Link
EP (1) EP0448299B1 (de)
JP (1) JPH0761957B2 (de)
AT (1) ATE106244T1 (de)
AU (1) AU643760B2 (de)
DE (1) DE69102174T2 (de)
DK (1) DK0448299T3 (de)
ES (1) ES2057759T3 (de)
FI (1) FI911269A (de)
IE (1) IE64891B1 (de)
NO (1) NO911022L (de)
NZ (1) NZ237332A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
US5505715A (en) * 1994-02-25 1996-04-09 Bristol-Myers Squibb Company Iontophoretic transdermal delivery of deoxyspergualin compounds
WO1995028145A1 (en) * 1994-04-18 1995-10-26 The Procter & Gamble Company Iontophoretic delivery of bisphosphonates to the alveolar bone
WO1998009665A2 (en) * 1996-09-04 1998-03-12 Becton Dickinson And Company Iontophoretic method of using phenylephrine to improve the effect of local anesthetics
CA2562932A1 (en) * 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine
WO2007041158A1 (en) * 2005-09-30 2007-04-12 Vyteris, Inc. Iontophoresis drug delivery device providing acceptable depth and duration of dermal anesthesia
FR2977493B1 (fr) * 2011-07-05 2014-02-14 Galderma Res & Dev Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
JP6371073B2 (ja) * 2013-02-22 2018-08-08 帝國製薬株式会社 イオントフォレシスで麻酔剤（局所麻酔薬）を導入する際に使用するパッチ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU609769B2 (en) 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US5013293A (en) * 1987-05-28 1991-05-07 Drug Delivery Systems Inc. Pulsating transdermal drug delivery system
US5334138A (en) * 1990-03-15 1994-08-02 North Carolina State University Method and composition for increased skin concentration of active agents by iontophoresis

Also Published As

Publication number Publication date
EP0448299A3 (en) 1991-12-27
NO911022L (no) 1991-09-16
EP0448299A2 (de) 1991-09-25
IE910716A1 (en) 1991-09-25
JPH0597709A (ja) 1993-04-20
IE64891B1 (en) 1995-09-20
AU7280191A (en) 1991-09-19
EP0448299B1 (de) 1994-06-01
NZ237332A (en) 1993-07-27
NO911022D0 (no) 1991-03-14
ES2057759T3 (es) 1994-10-16
AU643760B2 (en) 1993-11-25
ATE106244T1 (de) 1994-06-15
DK0448299T3 (da) 1994-06-20
FI911269A (fi) 1991-09-16
JPH0761957B2 (ja) 1995-07-05
FI911269A0 (fi) 1991-03-14
DE69102174T2 (de) 1994-09-08

Similar Documents

Publication Publication Date Title
EP0783299A4 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
BG103780A (en) Antitussive compositions
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DE69102174T2 (de) Iontophoresezusammensetzung zur Erhöhung der Hautkonzentration aktiver Wirkstoffe.
DE69105322D1 (de) Iontophoreseverfahren und -zusammensetzung.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
IL126175A (en) Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BECTON DICKINSON AND CO., FRANKLIN LAKES, N.J., US

8328 Change in the person/name/address of the agent

Free format text: JABBUSCH UND KOLLEGEN, 26135 OLDENBURG

8327 Change in the person/name/address of the patent owner

Owner name: DRUG DELIVERY TECHNOLOGIES, INC., FAIR LAWN, N.J.,

8327 Change in the person/name/address of the patent owner

Owner name: VYTERIS, INC. (N.D.GES.D. STAATES DELAWARE), FAIR

8339 Ceased/non-payment of the annual fee